Ian Shott, Turning the Potential into profits
Ian Shott was the founder, majority owner and CEO of Excelsyn, a fast growing Contract Development and Manufacturing business, focused on the global Pharmaceutical Industry. Excelsyn was sold to AMRI for $19 million dollars in February 2010.
Ian has held senior executive positions in the International Pharmaceutical Industry for over twenty years and has worked in the UK, France, Switzerland and the U.S.A. He was latterly President of RhodiaChirex’s Manufacturing Division having previously held executive board posts at Lonza and Zeneca. He has been particularly involved in creating and transforming businesses by a combination of break out development, organic growth, internal re-engineering and external merger, acquisition and divestment.
Ian was appointed a fellow of the Royal Academy of Engineering in July 2008 and is also a Fellow of both the Royal Society of Chemistry and the Institution of Chemical Engineers.
Ian is a Chemical Engineering graduate from Imperial College and was the Technical Vice President of the Institution of Chemical Engineers, from 2004 to 2007, becoming President in May 2009. He also Chairs the Board of the Centre of Excellence for Life Sciences (CELS). At Newcastle University he is a visiting professor, a member of Council and the founding chair of the Industrial Advisory Board for the schools of CEAM and Chemistry. He is additionally a member of the Industrial Advisory Boards for Chemical Engineering at Imperial College and Engineering Sciences at Oxford University as well as being a member the Strategy Advisory Board of the American Chemical Society and a founding board member of Britest.
He joined the Innovation Strategy Board for the Chemical Innovation–Knowledge Transfer Network in early 2007 and agreed to chair the UK’s Innovation Growth Team for Industrial Biotechnology in October 2007 subsequently joining the government’s Ministerial Advisory Group for Manufacturing Strategy in early 2008. He launched the Leadership Forum for Industrial Biotechnology, which he co-chairs with the Government Minister for Business, on 19th November 2009.
Ian was awarded a CBE in the Queen’s Birthday Honours of 2009.
March 2010